Logo image of GPI.MI

GPI SPA (GPI.MI) Stock Fundamental Analysis

BIT:GPI - Euronext Milan - IT0005221517 - Common Stock - Currency: EUR

10.44  0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to GPI. GPI was compared to 12 industry peers in the Health Care Technology industry. While GPI belongs to the best of the industry regarding profitability, there are concerns on its financial health. GPI is valued quite cheap, while showing a decent growth score. This is a good combination! GPI also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year GPI was profitable.
GPI had a positive operating cash flow in the past year.
Each year in the past 5 years GPI has been profitable.
Each year in the past 5 years GPI had a positive operating cash flow.
GPI.MI Yearly Net Income VS EBIT VS OCF VS FCFGPI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

1.2 Ratios

GPI has a better Return On Assets (10.91%) than 100.00% of its industry peers.
GPI has a Return On Equity of 33.74%. This is amongst the best in the industry. GPI outperforms 100.00% of its industry peers.
With a decent Return On Invested Capital value of 4.54%, GPI is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for GPI is below the industry average of 7.31%.
The 3 year average ROIC (3.61%) for GPI is below the current ROIC(4.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.91%
ROE 33.74%
ROIC 4.54%
ROA(3y)4.3%
ROA(5y)3.67%
ROE(3y)13.36%
ROE(5y)13.06%
ROIC(3y)3.61%
ROIC(5y)4.65%
GPI.MI Yearly ROA, ROE, ROICGPI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

With an excellent Profit Margin value of 20.96%, GPI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
GPI's Profit Margin has improved in the last couple of years.
GPI has a Operating Margin of 7.40%. This is comparable to the rest of the industry: GPI outperforms 58.33% of its industry peers.
In the last couple of years the Operating Margin of GPI has grown nicely.
The Gross Margin of GPI (71.31%) is comparable to the rest of the industry.
GPI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.4%
PM (TTM) 20.96%
GM 71.31%
OM growth 3Y0.35%
OM growth 5Y3.23%
PM growth 3Y83.16%
PM growth 5Y39.62%
GM growth 3Y-0.12%
GM growth 5Y0.09%
GPI.MI Yearly Profit, Operating, Gross MarginsGPI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GPI is destroying value.
GPI has more shares outstanding than it did 1 year ago.
GPI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, GPI has an improved debt to assets ratio.
GPI.MI Yearly Shares OutstandingGPI.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
GPI.MI Yearly Total Debt VS Total AssetsGPI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 1.22, we must say that GPI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.22, GPI is in line with its industry, outperforming 50.00% of the companies in the same industry.
A Debt/Equity ratio of 0.79 indicates that GPI is somewhat dependend on debt financing.
GPI has a Debt to Equity ratio (0.79) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Altman-Z 1.22
ROIC/WACC0.8
WACC5.68%
GPI.MI Yearly LT Debt VS Equity VS FCFGPI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

GPI has a Current Ratio of 1.37. This is a normal value and indicates that GPI is financially healthy and should not expect problems in meeting its short term obligations.
GPI has a Current ratio of 1.37. This is in the better half of the industry: GPI outperforms 66.67% of its industry peers.
A Quick Ratio of 1.32 indicates that GPI should not have too much problems paying its short term obligations.
The Quick ratio of GPI (1.32) is better than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.32
GPI.MI Yearly Current Assets VS Current LiabilitesGPI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

6

3. Growth

3.1 Past

GPI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1789.47%, which is quite impressive.
The Earnings Per Share has been growing by 43.78% on average over the past years. This is a very strong growth
The Revenue has grown by 16.92% in the past year. This is quite good.
GPI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.94% yearly.
EPS 1Y (TTM)1789.47%
EPS 3Y80.87%
EPS 5Y43.78%
EPS Q2Q%169.57%
Revenue 1Y (TTM)16.92%
Revenue growth 3Y15.3%
Revenue growth 5Y15.94%
Sales Q2Q%9.98%

3.2 Future

GPI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.34% yearly.
The Revenue is expected to grow by 6.35% on average over the next years.
EPS Next Y44.86%
EPS Next 2Y42.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.47%
Revenue Next 2Y6.35%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GPI.MI Yearly Revenue VS EstimatesGPI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
GPI.MI Yearly EPS VS EstimatesGPI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 2.91, which indicates a rather cheap valuation of GPI.
GPI's Price/Earnings ratio is rather cheap when compared to the industry. GPI is cheaper than 100.00% of the companies in the same industry.
GPI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.25.
Based on the Price/Forward Earnings ratio of 13.83, the valuation of GPI can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GPI indicates a somewhat cheap valuation: GPI is cheaper than 66.67% of the companies listed in the same industry.
GPI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.15, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 2.91
Fwd PE 13.83
GPI.MI Price Earnings VS Forward Price EarningsGPI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GPI is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.21
GPI.MI Per share dataGPI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

GPI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GPI has a very decent profitability rating, which may justify a higher PE ratio.
GPI's earnings are expected to grow with 42.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.06
PEG (5Y)0.07
EPS Next 2Y42.34%
EPS Next 3YN/A

9

5. Dividend

5.1 Amount

GPI has a Yearly Dividend Yield of 4.79%, which is a nice return.
Compared to an average industry Dividend Yield of 3.73, GPI pays a better dividend. On top of this GPI pays more dividend than 83.33% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, GPI pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.79%

5.2 History

On average, the dividend of GPI grows each year by 20.80%, which is quite nice.
Dividend Growth(5Y)20.8%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

23.56% of the earnings are spent on dividend by GPI. This is a low number and sustainable payout ratio.
The dividend of GPI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP23.56%
EPS Next 2Y42.34%
EPS Next 3YN/A
GPI.MI Yearly Income VS Free CF VS DividendGPI.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M
GPI.MI Dividend Payout.GPI.MI Dividend Payout, showing the Payout Ratio.GPI.MI Dividend Payout.PayoutRetained Earnings

GPI SPA

BIT:GPI (5/30/2025, 5:27:19 PM)

10.44

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners10.65%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap301.82M
Analysts82.86
Price Target17 (62.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.79%
Yearly Dividend0.85
Dividend Growth(5Y)20.8%
DP23.56%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.6%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.11%
Valuation
Industry RankSector Rank
PE 2.91
Fwd PE 13.83
P/S 0.61
P/FCF N/A
P/OCF 8.4
P/B 0.98
P/tB N/A
EV/EBITDA 7.21
EPS(TTM)3.59
EY34.39%
EPS(NY)0.75
Fwd EY7.23%
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)1.24
OCFY11.9%
SpS17.17
BVpS10.67
TBVpS-2.59
PEG (NY)0.06
PEG (5Y)0.07
Profitability
Industry RankSector Rank
ROA 10.91%
ROE 33.74%
ROCE 6.05%
ROIC 4.54%
ROICexc 5.01%
ROICexgc 16.53%
OM 7.4%
PM (TTM) 20.96%
GM 71.31%
FCFM N/A
ROA(3y)4.3%
ROA(5y)3.67%
ROE(3y)13.36%
ROE(5y)13.06%
ROIC(3y)3.61%
ROIC(5y)4.65%
ROICexc(3y)4.36%
ROICexc(5y)6.05%
ROICexgc(3y)13.88%
ROICexgc(5y)19.65%
ROCE(3y)4.81%
ROCE(5y)6.2%
ROICexcg growth 3Y-14.64%
ROICexcg growth 5Y-1.41%
ROICexc growth 3Y-17.1%
ROICexc growth 5Y-8.15%
OM growth 3Y0.35%
OM growth 5Y3.23%
PM growth 3Y83.16%
PM growth 5Y39.62%
GM growth 3Y-0.12%
GM growth 5Y0.09%
F-Score5
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Debt/EBITDA 2.72
Cap/Depr 96.85%
Cap/Sales 10.35%
Interest Coverage 1.8
Cash Conversion 40%
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 1.32
Altman-Z 1.22
F-Score5
WACC5.68%
ROIC/WACC0.8
Cap/Depr(3y)122.12%
Cap/Depr(5y)103.13%
Cap/Sales(3y)11.48%
Cap/Sales(5y)9.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1789.47%
EPS 3Y80.87%
EPS 5Y43.78%
EPS Q2Q%169.57%
EPS Next Y44.86%
EPS Next 2Y42.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.92%
Revenue growth 3Y15.3%
Revenue growth 5Y15.94%
Sales Q2Q%9.98%
Revenue Next Year6.47%
Revenue Next 2Y6.35%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y43.41%
EBIT growth 3Y15.71%
EBIT growth 5Y19.69%
EBIT Next Year176.63%
EBIT Next 3Y47.95%
EBIT Next 5YN/A
FCF growth 1Y50.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.66%
OCF growth 3Y41.24%
OCF growth 5Y24.83%